Apogee Therapeutics, Inc. · NASDAQ:APGE
Wellington Management Group LLP reported a 11.90% stake in Apogee Therapeutics, Inc. (Schedule 13G/A)
Event Mar 31, 2025 · Filed May 12, 2025
Wellington Management Group LLP reported a 11.90% stake in Apogee Therapeutics, Inc., 5,485,754 shares, as a passive investor on Mar 31, 2025. Filed May 12, 2025 (Schedule 13G/A).
- Stake
- 11.90%
- Shares
- 5,485,754
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Wellington Management Group LLP | 11.90% | 5,485,754 |
| Wellington Group Holdings LLP | 11.90% | 5,485,754 |
| Wellington Investment Advisors Holdings LLP | 11.90% | 5,485,754 |
| Wellington Management Company LLP | 11.60% | 5,485,754 |
Source
Related
- Apogee Therapeutics, Inc.
- Wellington Management Group LLP
- Apogee Therapeutics, Inc. shareholders
- Schedule 13G/A · Wellington Management Group LLP · Jul 8, 2026
- Schedule 13G/A · Wellington Management Group LLP · Feb 10, 2026
- Schedule 13G/A · Wellington Management Group LLP · Aug 5, 2025
- Schedule 13G/A · Wellington Management Group LLP · Aug 5, 2025
- Schedule 13D/A · Venrock Healthcare Capital Partners III, L.P. · Sep 8, 2026
- Form 4 · Fairmount Funds Management LLC · Sep 3, 2026
- Form 4 · McKenna Mark C. · Sep 3, 2026
- Form 4 · Jones William A Jr · Sep 3, 2026
- Form 4 · Dambkowski Carl · Sep 3, 2026